FDAFDA · Food and drugs·Recall number D-0028-2026
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Published October 22, 2025 · Recall initiated: October 8, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility:
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- FASENRA
- Manufacturer
- ASTRAZENECA PHARMACEUTICALS
- Distributor
- Nationwide in the U.S
- Lot
- Lot YJ0152, Expiry: 01/31/2028.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.